Global VC Hits Record $189B
Global VC funding hit a record $189B in February, up 780% year-over-year, with 83% going to OpenAI, Waymo, and Anthropic. Smart money is flowing into photonics ($500M) and patents ($25M), while specific raises include Outpost Bio $3.5M pre-seed for human microbiology and Antiverse $9.3M Series A for biotech antibodies. Bengaluru's Pronto reached $100M valuation in under a year with 10-minute home services.
The record-breaking venture capital landscape is heavily skewed towards established AI giants, with a recent KPMG report noting a market increasingly driven by fewer, larger transactions. This trend is exemplified by OpenAI's staggering $110 billion funding round, co-led by Amazon, Nvidia, and SoftBank. This massive influx of capital is structured around strategic partnerships, intertwining funding with long-term commitments for cloud computing and infrastructure, a model that could reshape how the AI sector is financed. Anthropic, a key competitor to OpenAI, recently more than doubled its valuation to $380 billion after a $30 billion Series G funding round. This surge in investor confidence is fueled by the rapid adoption of its AI model, Claude, particularly its enterprise-focused coding tool, which has seen significant revenue growth. The company's major backers include GIC, Coatue Management, and existing investors like Microsoft and Google. In the autonomous vehicle sector, Waymo recently secured a massive $16 billion investment, elevating its valuation to $126 billion. This funding is earmarked for an aggressive expansion into more than 20 new cities in 2026, including its first international markets, Tokyo and London. The company has demonstrated significant growth, tripling its annual ride volume to 15 million in 2025 and currently providing over 400,000 rides per week across six major U.S. metropolitan areas. Beyond the AI behemoths, "smart money" is flowing into deep tech sectors like photonics. This field, which harnesses light to improve data transport and system efficiency, is seen as a key enabling technology for a sustainable digital future. Venture capital firms are increasingly specializing in this area to identify and support companies developing next-generation solutions for data centers and quantum computing. The emphasis on patent investments reflects a broader venture capital strategy of securing a competitive advantage for portfolio companies. Patents provide legal protection for a startup's technology, creating barriers to entry for competitors and increasing the company's valuation. This is particularly crucial in innovation-driven fields like biotechnology and software. In the biotech sphere, early-stage funding remains robust. Outpost Bio, a London- and Boston-based startup, raised $3.5 million in a pre-seed round to develop its AI-driven models of human microbiology. The company aims to help pharmaceutical and consumer product companies design safer and more effective products by analyzing the complex interactions of microbial communities in the human body. Cardiff-based Antiverse secured a $9.3 million Series A to scale its AI-powered antibody discovery platform. This funding will accelerate the development of therapeutic antibodies for challenging disease targets and advance their internal drug pipeline. The company has now raised over $20 million in total. Bengaluru-based Pronto has demonstrated remarkable growth, achieving a $100 million valuation in under a year. The company, which offers on-demand home services, recently raised $25 million in a Series B round to expand its network of trained professionals. Pronto's success lies in its ability to formalize India's largely informal domestic help market through a structured, app-based platform, now handling over 18,000 bookings daily.
